Proteomics – Complete solutions for Epigenetics Research and Sample Preparation

Proteomics stands for the study of proteomes. Proteomes are the large-scale genome studies of proteins. Proteomics is essential to the field of medicine as it allows the detection and analysis of increasing numbers of molecules. Proteomics has enabled medical scientists to profile the function of thousands of genes in hundreds of thousands of tissues. Proteomics also enables the identification and mapping of thousands of protein-binding domains. Mass Spectrometry is one method used in proteomics. In recent years, other methods have emerged such as metabolite profiling, gene trapping, and DNA labeling. The majority of proteomics studies focus on the activities of single cells, focusing mainly on single genes and their function in generating disease.

Request Sample Copy of Proteomics Report @
https://www.coherentmarketinsights.com/insight/request-sample/2493

Competitive Landscape

Major companies contributing to the global proteomics market are PerkinElmer, Inc., Bruker, Caprion Proteomics Inc., Proteome Sciences, GE Healthcare, Bio-Rad Laboratories, Inc., Danaher Corporation, Inc., Agilent Technologies, Thermo Fisher Scientific Corporation, Sera Prognostics, Inc., Center for Genomic Sciences, Luminex Corporation, Xcelris Genomics., Courtagen Life Sciences, Inc., Waters Corporation, Applied Biomics, Inc., Newomics, Inc., Cell Signaling Technology, Inc., and Biognosys Inc.

Drivers

Increasing investments in the drug discovery and development activities coupled with the rising demand for at-home personal-care drugs are expected to boost growth of the proteomics market throughout the forecast period.

Furthermore, rising demand for biomarker identification amidst technological advancements is expected to propel growth of the proteomics market during the forecast period.

The Epitome of the COVID-19 Aftermath

The ongoing prevalence of the pandemic is providing the impetus to the global proteomics market. The outbreak of the virus has sparked a row of R&D activities to identify the 3D structure of the SARS-CoV-2, thus, paving a way of opportunities for the global proteomics market. Under the uncertainties of COVID-19, the market is foreseen to accelerate the identification of novel biomarkers.

Request PDF Report Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2493

Key Takeaways

The proteomics market is anticipated to grow at a CAGR of XX % during the forecast period owing to the increasing occurrences of genetic disorders and rising pharmaceutical investments. For instance, in August 2021, the National Institutes of Health (NIH) reported that Neurofibromatosis type I, a genetic disorder, affects 1 in 3,000 individuals globally.

From a geographical standpoint, the proteomics market in the North American region is poised to witness a substantial growth on the view of a robust pharmaceutical sector and rising healthcare investments.

Another noteworthy geographic region is Asia Pacific which is driving monetary growth for the proteomics market on account of increased R&D activities on omics and drug structure.

Also, Research Report Examines:

• Competitive companies and manufacturers in global market

• By Product Type, Applications & Growth Factors

• Industry Status and Outlook for Major Applications / End Users / Usage Area

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.